期刊文献+

紫杉醇和顺铂诱导下的凋亡卵巢癌细胞对树突细胞提呈功能影响 被引量:2

Effect of apoptotic ovarian cancer cells induced by paclitaxel-cisplatin on antigen presentation function of DC
原文传递
导出
摘要 目的:本研究旨在探索紫杉醇、顺铂诱导卵巢癌细胞凋亡后能否具有较强的免疫原性,并可以被抗原提呈细胞交叉提呈并促进免疫应答。方法:用巨噬细胞-集落刺激因子(GM-CSF)和白介素-4(IL-4)刺激人外周血单核细胞分化诱导为树突状细胞(DC),6d后将DC和经紫杉醇联合顺铂在体外诱导发生凋亡的人卵巢癌细胞株共同培养,并以冻融细胞共培养DC组和单独DC组作对照,共培养4h后,进行激光扫描共聚焦显微镜观察DC细胞对凋亡细胞的吞噬作用,同时以流式细胞术(FCM)检测不同培养组DC的分化和成熟程度。结果:紫杉醇、顺铂诱导的凋亡卵巢癌细胞可被DC有效吞噬,与对照组相比,凋亡组DCs的表达及成熟度均明显增高,并具有统计学意义(P(0.05)。结论:紫杉醇、顺铂诱导的凋亡卵巢癌细胞具有较强的免疫原性,可以促进DC的分化和成熟。 AIM: To explore wheather apoptotic ovarian cancer cells induced by paclitaxel-cisplatin could be crosspresented by antigen presenting cells and promote immune responses. METHODS: DCs were generated from peripheral blood monocytes in RPMI1640 supplemented with GMCSF and IL-4. After 6 days' incubation, DCs were further co-cultured with either apoptotic HO8910 cell lines induced by paclitaxel-cisplatin or control cells for four hours. Maturation of DCs was compared among different groups according to their surface markers through flow cytometry assay and their phagocytosis ability was evaluated by confocal microscopy scanning assay. RESULTS: Apoptotic ovarian cancer cells induced by paclitaxel-cisplatincan were phagocytized more efficiently by DCs. Resulting is more cellularity and maturation of DCs in apoptotic cell-induced groups than control group ( P 〈 0.05 ). CONCLUSION: Apoptotic ovarian cancer cells induced by paclitaxel-cisplatin exhibit strong immunogenicity, which in turn promote the maturation and antigen presentation of DCs.
出处 《细胞与分子免疫学杂志》 CAS CSCD 北大核心 2009年第1期38-41,共4页 Chinese Journal of Cellular and Molecular Immunology
基金 上海市教育委员会科研项目(061012)
关键词 紫杉醇 顺铂 树突状细胞 细胞凋亡 抗原提呈 paclitaxel cisplatin dendritic cells apoptoticcells antigen presentation
  • 相关文献

参考文献7

  • 1Correale P, Cusi MG, Del Vecchio MT, et al. Dendritic cell-mediated cross-presentation of antigens derived from colon carcinoma cells exposed to a highly cytotoxic multidrug regimen with gemcitabine, oxaliplatin, 5-fluorouracil, and leucovorin, elicits a powerful human antigen-specific CTL response with antitumor activity in vitro[ J]. J Immunol, 2005, 175(2) : 820 -828.
  • 2Coukos G, Conejo-Gareia JR, Ronder RB, et al. Immunotherapy for gynaecological malignancies [ J ]. Expert Opin Biol Ther, 2005,5 (9) : 1193 - 1210.
  • 3Vari F, Hart DN. Loading DCs with Ag [ J ]. Cytotherapy, 2004, 6 (2): 111-121.
  • 4Ward S, Casey D, Labarthe MC, et al. Immunotherapeutic potential of whole tumor cells [ J ]. Cancer Immunol Immunother, 2002, 51 (5) : 351 -357.
  • 5Nowak AK, Lake RA, Marzo AL, et ol. Induction of tumor cell apoptosis in vivo increases tumor antigen eross-presentation, cross-priming rather than cross-tolerizing host tumor-specific CD8 T cells[ J]. J Immunol, 2003, 170(10) : 4905 -4913.
  • 6Van der Most RG, Currie A, Robinson BW, et al. Cranking the iramunologic engine with chemotherapy : using context to drive tumor antigen cross-presentation towards useful antitumor immunity[ J]. Cancer Res, 2006, 66(2) : 601 -604.
  • 7Casares N, Pequignot MO, Tesniere A, et al. Caspase-dependent immunogenicity of doxorubicin-induced tumor cell death [ J ]. J Exp Med, 2005, 202(12) : 1691 - 1701.

同被引文献31

  • 1李康,郭强,王翠妮,陈敏,徐薇,熊思东.M1和M2型巨噬细胞表型的比较分析[J].现代免疫学,2008,28(3):177-183. 被引量:63
  • 2尹华华,朱京慈,李磊.巨噬细胞的异质性[J].细胞与分子免疫学杂志,2004,20(4):510-512. 被引量:9
  • 3Zhao J, Kim J E, Reed E, et al. Molecular mechanism of antitumor activity of taxanes in lung cancer (Review) [J].Int J Oncol,2005,27 (1):247-256.
  • 4Kim Y M, Paik S G. Induction of expression of inducible nitric oxide synthase by Taxol in murine macrophage cells[J].Biochem Biophys Res Commun,2005,326(2):410-416.
  • 5Lee B H, Lee J E, Lee K W, et al. Coating with paclitaxel improves graft survival in a porcine model of haemodialysis graft stanosis[J]. Nephrol Dial Transpl,2007,22(lO):2800-2804.
  • 6Reyes-Corona J, Gortzalez-Huezo M S, Zea-Medina M V, et al. Paclitaxel coated-stant for early-onset thrombosis after liver transplantation[J].Ann Hepatol,2007, 6(4):272-275.
  • 7Gordon S. Macrophage heterogeneity and tissue lipids[J]. J. Clin Invest,2007,117: 89-93.
  • 8Laskin D L, Weinberger B, Laskin J D. Functional heterogeneity in liver and lung macrophages[J].J Leukocyte Biol,2001,70(2): 163-170.
  • 9Gordon S. Alternative activation of macrophages[J].Nat Rev Immunol,2003,3(1): 23-35.
  • 10Zaks-Zilberman M, Zaks T Z, Vogel S N. Induction of proinflammatory and chemokine genes by lipopolysaccharide and paclitaxel (Taxol) in murine and human breast cancer cell lines[J]. Cytokine,2001,15(3): 156-165.

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部